Pfizer sues Alembic, Zydus (and Watson) over US Pristiq ANDAs
This article was originally published in Scrip
Executive Summary
Pfizer has sued a clutch of Indian firms in a suit concerning their US abbreviated new drug applications (ANDAs) for its antidepressant Pristiq (desvenlafaxine succinate).